Synergy between an IGF-1R antibody and Raf/MEK/ERK and PI3K/Akt/mTOR pathway inhibitors in suppressing IGF-1R-mediated growth in hematopoietic cells

Leukemia
F E BertrandJ A McCubrey

Abstract

The Insulin-like growth factor-1 receptor (IGF-1R) is overexpressed in a variety of tumors including breast, prostate and myeloma. Thus, IGF-1R and its downstream signaling effectors are good candidates for molecular-based targeted antitumor therapies. Indeed, protein inhibitors of IGF-1R signaling and IGF-1R blocking antibodies are undergoing clinical trials. Herein, the molecular basis for antibody-mediated IGF-1R signal inhibition has been investigated in a hematopoietic cell line model, FDC-P1, that has been rendered interleukin-3 independent in a ligand-dependent manner through retroviral-mediated expression of IGF-1R (FD/IGF-1R). Furthermore, the ability of an anti-IGF-1R antibody to synergize with signal-transduction pathway inhibitors and induce apoptosis was determined. The alphaIGF-1R antibody, A12, was capable of arresting IGF-1 or insulin-induced FD/IGF-1R cell proliferation in the G1 phase of the cell cycle and resulted in apoptotic induction. A12 effectiveness could be potentiated through combination treatment with small molecule inhibitors of the Ras/Raf/MEK/ERK or PI3K/Akt/mTOR pathways. These results validate the use of the FD/IGF-1R cells to evaluate the effectiveness and mechanisms of targeted IGF-1R therapeu...Continue Reading

References

Apr 26, 2000·Pediatric Hematology and Oncology·J Blatt
Aug 1, 2000·Immunology Today·M J Glennie, P W Johnson
May 29, 2001·Molecular Pathology : MP·B Valentinis, R Baserga
May 28, 2003·Cancer Letters·Derek LeRoith, Charles T Roberts
Nov 6, 2003·International Journal of Cancer. Journal International Du Cancer·Renato BasergaKrysztof Reiss
Jan 29, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ki Young ChungLeonard B Saltz
Mar 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Bruce D CohenJames D Moyer
Apr 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jennifer D WuStephen R Plymate

❮ Previous
Next ❯

Citations

Oct 6, 2010·Cancer Metastasis Reviews·Carlos A CastanedaEva M Ciruelos
May 3, 2011·Targeted Oncology·Sushma VemulapalliMonica Mita
Jun 6, 2008·Current Opinion in Oncology·Katia Scotlandi, Piero Picci
Nov 6, 2010·Sarcoma·Vivek Subbiah, Pete Anderson
Mar 13, 2013·The Journal of Clinical Investigation·Kfir LapidTsvee Lapidot
Apr 9, 2010·Future Oncology·Pooja Hingorani, Edward A Kolb
Jun 25, 2009·Expert Opinion on Investigational Drugs·Kevin P McKian, Paul Haluska
Feb 24, 2009·Archives of Physiology and Biochemistry·Eline MenuKarin Vanderkerken
Aug 20, 2011·Cancer Epidemiology·Xiaoqun DongDonghui Li
Dec 5, 2009·Best Practice & Research. Clinical Haematology·Steven Grant
Jan 9, 2010·Seminars in Oncology·Janet E DanceyJoseph Purvis
Mar 27, 2007·Advances in Enzyme Regulation·James A McCubreyAlberto M Martelli
May 8, 2013·International Journal of Cancer. Journal International Du Cancer·Feifei LiLili Wang
Jun 7, 2014·Expert Opinion on Therapeutic Targets·Niamh A KeaneMichael O'Dwyer
Feb 22, 2012·Upsala Journal of Medical Sciences·Helena Jernberg-Wiklund, Kenneth Nilsson
Aug 16, 2014·Cancer Treatment Reviews·Helen KingValentine M Macaulay
Sep 24, 2016·Oncotarget·Deeksha VishwamitraHesham M Amin
Jul 4, 2012·Molecular and Cellular Biochemistry·Qin PengYuanliang Wang
Nov 28, 2012·Journal of Cancer Research and Clinical Oncology·Axel MuendleinMichael Hubalek
Sep 21, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Sara A FlaniganStephen Leong

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Antibody Specificity

Antibodies produced by B cells are highly specific for antigen as a result of random gene recombination and somatic hypermutation and affinity maturation. As the main effector of the humoral immune system, antibodies can neutralize foreign cells. Find the latest research on antibody specificity here.